Mark I. Kemp
Impact in
-
- Neuroscience and Neuropharmacology Research
-
- Ubiquitin and proteasome pathways
- Ion channel regulation and function
- Nicotinic Acetylcholine Receptors Study
- Histone Deacetylase Inhibitors Research
Papers in
-
- Ion channel regulation and function 5
- Protein Degradation and Inhibitors 3
- Nicotinic Acetylcholine Receptors Study 3
- Ubiquitin and proteasome pathways 3
-
- Neuroscience and Neuropharmacology Research 4
- Co-authors
- Stephen P. Jackson (3 shared papers)Xavier Jacq (2 shared papers)Niall M.B. Martin (2 shared papers)Rhys D.O. Jones (1 shared paper)Kevin Beaumont (1 shared paper)C.A.R. Boyd (1 shared paper)David B. Sattelle (1 shared paper)Valérie Raymond (1 shared paper)
- Journals
- Synthesis (2 papers)Progress in medicinal chemistry (2 papers)Cell Biochemistry and Biophysics (1 paper)ACS Medicinal Chemistry Letters (1 paper)Tetrahedron Letters (1 paper)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Mark I. Kemp
14 papers receiving 387 citations
Peers
Comparison fields: 5 of 62
- Cellular and Molecular Neuroscience 81
- Molecular Biology 288
- Oncology 70
- Organic Chemistry 66
- Pharmacology 37
Countries citing papers authored by Mark I. Kemp
This map shows the geographic impact of Mark I. Kemp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark I. Kemp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark I. Kemp more than expected).
Fields of papers citing papers by Mark I. Kemp
This network shows the impact of papers produced by Mark I. Kemp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark I. Kemp. The network helps show where Mark I. Kemp may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark I. Kemp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 73 | |
| 2 | 2016 | 57 | |
| 3 | 2023 | 43 | |
| 4 | 2005 | 42 | |
| 5 | 2015 | 36 | |
| 6 | 2009 | 35 | |
| 7 | 1998 | 34 | |
| 8 | 2018 | 22 | |
| 9 | 2010 | 14 | |
| 10 | 1994 | 13 | |
| 11 | 1998 | 9 | |
| 12 | 1998 | 8 | |
| 13 | 2016 | 5 | |
| 14 | 2000 | 4 | |
| 15 | 2015 | 1 |
About Mark I. Kemp
Mark I. Kemp is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Organic Chemistry, Pharmacology and Oncology, having authored 15 papers that have together received 396 indexed citations. Recurring topics across this work include Ion channel regulation and function (5 papers), Neuroscience and Neuropharmacology Research (4 papers), Protein Degradation and Inhibitors (3 papers), Nicotinic Acetylcholine Receptors Study (3 papers), Ubiquitin and proteasome pathways (3 papers), Synthetic Organic Chemistry Methods (2 papers), Cholinesterase and Neurodegenerative Diseases (2 papers) and Asymmetric Synthesis and Catalysis (2 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (81 citations), Molecular Biology (288 citations), Oncology (70 citations), Organic Chemistry (66 citations) and Pharmacology (37 citations). Mark I. Kemp has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Stephen P. Jackson, Xavier Jacq, Niall M.B. Martin, Rhys D.O. Jones, Kevin Beaumont, C.A.R. Boyd, David B. Sattelle, Valérie Raymond, Steven D. Buckingham and Sharan K. Bagal. Their work appears in journals such as Synthesis, Progress in medicinal chemistry, Cell Biochemistry and Biophysics, ACS Medicinal Chemistry Letters and Tetrahedron Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.